Zurit Levine

发表

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

N. Stanietsky, H. Šimić, J. Arapović, 2009, Proceedings of the National Academy of Sciences.

Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)

Helge G. Roider, O. Levy, Z. Levine, 2020, Cancer Immunology Research.

Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors*

Eyal Gofer, Avi Rosenberg, A. Toporik, 2008, Journal of Biological Chemistry.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016, Journal for ImmunoTherapy of Cancer.

ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses

A. Toporik, Amit Novik, Z. Levine, 2018, The Journal of Immunology.

Peptides modulating conformational changes in secreted chaperones: From in silico design to preclinical proof of concept

Haim Ashkenazy, Ofer Levy, Amit Novik, 2009, Proceedings of the National Academy of Sciences.

Large-scale protein annotation through gene ontology.

Avi Shoshan, Vladimir Grebinskiy, Alon Wasserman, 2002, Genome research.

A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway

I. Tsarfaty, J. Horev, Dalit Landesman-Milo, 2008, Clinical Cancer Research.

Systematic antigenic profiling of hematopoietic antigens on ovarian carcinoma cells identifies membrane proteins for targeted therapy development.

Z. Levine, D. Grisaru, Y. Kinar, 2009, American journal of obstetrics and gynecology.